anne dejeanassémat born january french molecular biologist working mechanisms leading development human cancers professor pasteur institute research director inserm heads laboratory nuclear organization pasteur institute anne dejeanassémat educated pierre marie curie university paris graduating master science degree genetics earned phd pierre tiollais laboratory pasteur institute thesis investigated role integrated hepatitis b virus sequences development hepatocellular appointed head pasteur instituteinserm laboratory member embo french academy sciences american academy arts sciences received gagna van heck prize prize loréalunesco women science grand prix inserm sjöberg prize cancer molecular biologist anne dejeanassémat contributed several pioneering concepts areas nuclear receptors human cancers discovered genes encoding receptors retinoic acid rar active derivative vitamin mutated liver cancer rare type leukemia deciphered molecular cellular bases cure leukemia opening unique perspectives new differentiation targeted cancer therapy leadscitation needed first found mutation hepatitis b virusassociated liver tumor demonstrating virus inserting genome hepatic cell disrupt neighbouring human genes directly trigger development liver discovery led dejeanassémats team clone rarb gene identify first responsive element retinoic together hugues de thé discovered pmlrara oncoprotein genetic defect responsible acute promyelocytic leukemia apl elucidated oncogenic dejeanassémats work led characterization mechanisms underlying cure apl retinoic acid arsenic treatment developed china remains efficient oncogenetargeted therapy described showed therapeutic doses retinoic acid correct deficient molecular response leukemic also demonstrated particular organelle pml nuclear body disrupted cells retinoic acid arsenic able correct cellular showed arsenic induces posttranslational modification pmlrara small sumo protein well degradation dejeanassémats laboratory next contributed emergence sumo field unveiling yet unanticipated function pathway major epigenetic determinant gene expression regulation key role repression innate maintenance cell work opened exciting new avenues regenerative medicine cancer treatment pharmacological modulation sumoylation levels articles published anne dejeanassémats laboratory retracted pointing instances image pasteur institute cnrs inserm launched joint investigation research misconduct conclusion indicates one staff scientist laboratory left institut pasteur april engaged fraudulent anne dejeanassémat held several scientific advisory positions served scientific council president genetics development cancer committee inserm received mergierbourdeix prize french academy sciences rosen prize medical research foundation mitjaville prize national academy medicine hamdan award medical research excellence therapy leukemia gagna van heck prize léopold griffuel prize association de recherche en cancérologie arc prize loréalunesco women duquesne prize la ligue nationale contre le cancer grand prix sjöberg prize royal swedish academy awarded two advanced grants european research council erc appointed officer ordre national du mérite ordre national de la légion anne dejeanassémat member european molecular biology organisation embo french academy science academia europaea european academy cancer sciences american academy arts sciences